DCT Implementation


DTRA 2024: GSK and Medable discuss change management and DCTs
On Friday, November 15, 2024, the Decentralized Trials & Research Alliance (DTRA) held a fireside chat between Brandon Maggio, GSK’s Global Head of Digital Operations & Process Optimization, and Alison Holland, Medable’s Chief Customer Officer. They were gathered to discuss the evolving landscape of decentralized and digital clinical trials and how best to drive change management in an era of continual changes within trial research. The following blog is a summary of their discussion.


Technology Overload: Addressing Site Challenges of Digital Trials
Katie madden, Digital & Process Optimization at GSK, joins Medable’s Andrew MacKinnon and Annie Hesslewood to discuss the importance of implementing a change management strategy coupled with a unified digital trial platform that streamlines eConsent, eCOA, sensors, and integration workflows into a single end-to-end experience.


What it really takes to adopt eConsent across large pharma
Learn about the benefits of adopting consent management technology and best practices around developing change management and training programs to help sponsors, CROs and sites get the most out of eConsent.